New combo therapy tested to halt spreading skin condition
NCT ID NCT04237103
Summary
This study tested if adding a weekly oral medication (methotrexate) to standard UVB light therapy was better at controlling active, spreading vitiligo than light therapy alone. It involved 32 adults whose vitiligo was getting worse. Researchers measured changes in skin color, disease activity, and quality of life over 8 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier de Pau
Pau, 64000, France
-
Centre Hospitalier de Périgueux
Périgueux, 24000, France
-
Service de Dermatologie - CHU de Toulouse - Hopital Purpan
Toulouse, 31059 Toulouse Cedex, France
-
Service de Dermatologie - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France
Conditions
Explore the condition pages connected to this study.